GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » EV-to-FCF

Olympus (TSE:7733) EV-to-FCF : 19.51 (As of Mar. 03, 2025)


View and export this data going back to 1949. Start your Free Trial

What is Olympus EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Olympus's Enterprise Value is 円2,310,058 Mil. Olympus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was 円118,411 Mil. Therefore, Olympus's EV-to-FCF for today is 19.51.

The historical rank and industry rank for Olympus's EV-to-FCF or its related term are showing as below:

TSE:7733' s EV-to-FCF Range Over the Past 10 Years
Min: -1560.68   Med: 48.94   Max: 340.09
Current: 19.51

During the past 13 years, the highest EV-to-FCF of Olympus was 340.09. The lowest was -1560.68. And the median was 48.94.

TSE:7733's EV-to-FCF is ranked better than
64.34% of 373 companies
in the Medical Devices & Instruments industry
Industry Median: 28.2 vs TSE:7733: 19.51

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-03), Olympus's stock price is 円2047.00. Olympus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was 円74.740. Therefore, Olympus's PE Ratio (TTM) for today is 27.39.


Olympus EV-to-FCF Historical Data

The historical data trend for Olympus's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus EV-to-FCF Chart

Olympus Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.42 47.37 28.27 110.05 -113.72

Olympus Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.02 -113.72 53.20 37.68 22.59

Competitive Comparison of Olympus's EV-to-FCF

For the Medical Devices subindustry, Olympus's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Olympus's EV-to-FCF falls into.



Olympus EV-to-FCF Calculation

Olympus's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2310058.288/118411
=19.51

Olympus's current Enterprise Value is 円2,310,058 Mil.
Olympus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円118,411 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus  (TSE:7733) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Olympus's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2047.00/74.740
=27.39

Olympus's share price for today is 円2047.00.
Olympus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円74.740.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Olympus EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Olympus's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

Olympus Headlines

No Headlines